PSMA8
Proteasome subunit alpha-type 8
Also known as: MGC26605, PSMA7L, PSMA8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAA3
- Gene
- PSMA8
- Ensembl
- ENSG00000154611
- Chromosome
- 18
- Canonical length
- 256 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Principal piece
OverviewNCBI Gene
Predicted to be involved in meiotic cell cycle and proteasome-mediated ubiquitin-dependent protein catabolic process. Located in extracellular exosome and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
256 residues, UniProt reviewed canonical sequence.
>Q8TAA3|PSMA8
1 MASRYDRAIT VFSPDGHLFQ VEYAQEAVKK GSTAVGIRGT NIVVLGVEKK SVAKLQDERT
61 VRKICALDDH VCMAFAVLTI FIGLTADARV VINRARVECQ SHKLTVEDPV TVEYITRFIA
121 TLKQKYTQSN GRRPFGISAL IVGFDDDGIS RLYQTDPSGT YHAWKANAIG RSAKTVREFL
181 EKNYTEDAIA SDSEAIKLAI KALLEVVQSG GKNIELAIIR RNQPLKMFSA KEVELYVTEI
241 EKEKEEAEKK KSKKSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMA8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- testis: 16 nTPM
- tonsil: 1.6 nTPM
- lymph node: 1.3 nTPM
- thymus: 0.5 nTPM
- appendix: 0.4 nTPM
- placenta: 0.2 nTPM
Single-cell type
- early primary spermatocytes: 288 nCPM
- late primary spermatocytes: 126 nCPM
- sertoli cells: 32 nCPM
- differentiating spermatogonia: 13 nCPM
- undifferentiated spermatogonia: 11 nCPM
- early spermatids: 5.9 nCPM
Immune cell
- naive CD8 T-cell: 1.9 nTPM
- T-reg: 1.6 nTPM
- memory B-cell: 1.4 nTPM
- memory CD8 T-cell: 1.2 nTPM
- naive B-cell: 1.2 nTPM
- naive CD4 T-cell: 0.9 nTPM
Brain region
- hypothalamus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- pons: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- meiotic cell cycle
- proteasomal protein catabolic process
- proteasome-mediated ubiquitin-dependent protein catabolic process
- regulation of meiosis I
- spermatogenesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMA8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMA8 as an antibody target. Whether an autoantibody or antibody against PSMA8 could matter depends on whether native PSMA8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMA8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSMA8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...